Two Genetic Mutations Linked to Tumor Behavior in Thyroid Cancer Patients
CDC27 mutations may be associated with less aggressive behavior while SLC25A5 mutations may be associated with more aggressive behavior in papillary thyroid carcinomas.
Papillary Thyroid Cancer
Study: Survival Is ‘Excellent’ in Pediatric Differentiated Thyroid Cancer
However, nearly one-third of patients develop lifelong complications following thyroid surgery.
Obesity May Raise Thyroid Cancer Risk
Positive link to papillary, follicular, anaplastic thyroid cancer; inverse link for medullary thyroid cancer.
Cervical Lymph Node Metastases Linked to Lower Survival in Thyroid Cancer
Cervical lymph node metastases are associated with compromised survival in young patients with papillary thyroid cancer.
HABP2 Mutation Confers Susceptibility to Thyroid Cancer
HABP2 G534E variant is a susceptibility gene for familial nonmedullary thyroid cancer and functions as a dominant-negative tumor-suppressor gene.
Effect of Timing of Postop Radioactive Iodine Ablation in PTC
Timing of radioactive iodine ablation doesn’t affect overall survival in papillary thyroid cancer.
Could Dogs Sniff Out Thyroid Cancer?
A trained scent dog was able to accurately identify thyroid cancer in urine samples from patients with thyroid nodules.
Benign Thyroid Nodules: When Should Repeat Evaluation Be Performed?
Kenneth D. Burman, MD, discusses one study suggesting that the optimal time for repeat evaluation of benign thyroid nodules is 2 to 4 years.
New Assay May Help Guide Therapy in Papillary Thyroid Cancer
A blood assay that measures BRAF mutation levels may be helpful in diagnosing and monitoring papillary thyroid cancer.
Radioiodine Has Small Benefit in Papillary Thyroid Cancer
Radioactive iodine therapy may slightly improve survival in papillary thyroid carcinoma.
